Antigen-specific Therapies

High-throughput selection of pathogen specific antimicrobials from random sequence peptide microarrays

Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury